Glucosamine


Generic Medicine Info
Administration
Should be taken with food. Preferably taken at meals.
Contraindications
Hypersensitivity to glucosamine and shellfish. Children.
Special Precautions
Patient with impaired glucose tolerance, diabetes mellitus, asthma; known risk factors for CV disease. Rule out the presence of other joint diseases. Not indicated for the treatment of acute painful symptoms. Renal and hepatic impairment. Pregnancy and lactation. Patient Counselling This drug may cause dizziness or drowsiness, if affected, do not drive or operate machinery. Monitoring Parameters Monitor blood glucose levels prior to and periodically thereafter (in patients with impaired glucose tolerance); cholesterol levels (in at risk for CV disease).
Adverse Reactions
Significant: Asthma exacerbation, hypercholesterolaemia, worsened blood glucose control. Gastrointestinal disorders: Nausea, vomiting, diarrhoea, constipation, abdominal pain, heartburn, flatulence, dyspepsia. General disorders and administration site conditions: Fatigue, peripheral oedema. Hepatobiliary disorders: Jaundice. Investigations: Elevated hepatic enzymes. Nervous system disorders: Headache, dizziness, drowsiness. Skin and subcutaneous tissue disorders: Rash, pruritus, erythema, angioedema, urticaria. Vascular disorders: Flushing.
Drug Interactions
May increase the anticoagulant effects of warfarin and acenocoumarol. May increase the absorption and serum levels of tetracyclines.
CIMS Class
Supplements & Adjuvant Therapy
ATC Classification
M01AX05 - glucosamine ; Belongs to the class of other non-steroidal antiinflammatory and antirheumatic products.
Disclaimer: This information is independently developed by CIMS based on glucosamine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
MORE
LESS
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in